HIGHLIGHTS
- who: John S. Tzartos et al. from the nd Department of Neurology, School of Medicine, National and Kapodistrian University of Athens, General University Hospital, Athens, Greece have published the article: Plasma P-Tau181 for the Discrimination of Alzheimer’s Disease from Other Primary Dementing and/or Movement Disorders, in the Journal: Biomolecules 2022, 1099 of /2022/
- what: CSF biomarkers still remain the gold standard for "fluid-based diagnosis" of AD.
- how: In the study the AUC of plasma pT181-Tau was at the level of 0.83 thus comparable to the previously described . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.